Science journalism by Leonid Schneider, on research integrity and academic publishing in life sciences and biomedicine
As a young Wunderkind, Josef Penninger discovered the ACE2 receptor. Now he invented the cure for the coronavirus which will work in his hands where Big Pharma failed. He was never found guilty of research misconduct and never retracted a paper. Dr Penninger is a Genius making a COVID-19 vaccine.
Guido Kroemer receives on 8 November 2019 the €1mn Lombardy Award for Healthy Ageing, at La Scala in Milan. And why not, one panel member was Carlo Croce.
St Carlos of Oviedo almost was canonised as Spain’s first living martyr, but now Nature revoked his mentoring award. Spanish media and science elites are desperate, even the Queen is not amused. The Royal Academy of Sciences insists Lopez-Otin is a victim of journal’s failure.
I obtained a partial script of a stage play which recently premiered in Paris: “La Passion de Don Carlos”. Any similarities with Spanish or French cancer researchers are entirely coincidental.
Catherine Jessus resigned, Olivier Voinnet solves the crime he was suspected of, and their mutual investigator Francis-Andre Wollman might want to investigate his own papers
Following my reporting, the cancer researcher Carlos López-Otín abandoned his ERC-funded 36-member-strong “Degradome” lab at the University of Oviedo in Spain and moved in with his collaborator in Paris, France, Guido Kroemer. Yet Lopez-Otin’s data integrity issues seem as poppycock compared to what Kroemer and his life partner Laurence Zitvogel dished out to the scientific community.
